Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Baird Small/Mid Cap Growth Equity Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum over fundamental quality, prompting tactical additions to beta and momentum."
The Baird Small/Mid Cap Growth strategy declined -3.22% (Net) in Q3 2025, significantly underperforming its primary benchmark, the Russell 2500 Growth Index, which rose +10.73%. This represents the worst relative performance since the strategy's inception ten years ago. The major headwind was a structural market pivot toward high-beta, high-momentum, and speculative AI/story stocks (including quantum computing), which heavily penalized high-quality factors like high ROE, ROIC, and stable earnings growth. In response, the managers executed selective portfolio adjustments—selling AAON and Texas Roadhouse, and initiating positions in Affirm, SoFi, Twilio, and ServiceTitan—to introduce more momentum and beta exposure while retaining their core high-quality disciplines.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Growth Outlook
Market outlook remains moderate conviction: Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Risk Appetite
Risk appetite posture is moderate conviction: Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Forward Guidance
Forward guidance signal: Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Language Signal
Tone analysis indicates above average conviction language: Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Perceived Risk
Perceived risk level is evaluated as above average conviction. Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
Time Horizon
Investment time horizon reflects a high conviction orientation. Baird Small/Mid Cap Growth suffered its worst relative quarter in 10 years (-3.22% vs. +10.73% benchmark) due to a speculative market favoring extreme AI valuations and momentum ov...
